AMC stock surges as Taylor Swift concert crosses $100 million in advance ticket sales
By James Rogers
"Taylor Swift The Eras Tour" hits more than 8,500 movie theaters globally in 100 countries on Oct. 13
Shares of movie theater chain and meme stock darling AMC Entertainment Holdings Inc. surged more than 10% Friday after the company announced that the "Taylor Swift The Eras Tour" concert film has brought in more than $100 million in global advance ticket sales revenue.
The eagerly anticipated movie debuts on Friday Oct.13, hitting more than 8,500 theaters in 100 countries worldwide, AMC (AMC) said, in a statement Thursday. "Audience demand for 'Taylor Swift The Eras Tour' concert film has been incredible from the moment it was first announced," AMC added.
Related: AMC clinches deal to show Beyoncé's 'Renaissance World Tour' concert film
AMC is the theatrical distributor for "Taylor Swift The Eras Tour," clinching deals with Cinemark Holdings Inc. (CNK) and Regal in the U.S., Cineplex (CA:CGX) in Canada and Cinepolis in Mexico to show the film.
In North America, AMC Theatres Distribution has reached agreements to show the film at nearly 4,000 movie theaters, starting Oct. 13, AMC said.
Related: From Taylor Swift and Beyoncé to blockchain and AI: Music ETF CEO eyes the next big thing
AMC recently announced that the film had shattered the company's record for single-day advance ticket sales, with $26 million in ticket revenue sold on Aug. 31. The company's shares rose 10.5% Friday, outpacing the S&P 500 index's SPX gain of 1.1%. Cinemark's stock rose 4.1%.
Last month Cinemark announced Private Swiftie Parties, where fans can hire a private auditorium to watch the film.
Related: 'Taylor Swift: The Eras Tour' sets pre-sales records for Cinemark
Major concert films are in the spotlight, boosted by high-profile tours from Taylor Swift and Beyoncé, whose "Renaissance: A Film by Beyoncé" will hit cinemas next month. On Monday Cinemark announced that preshows for Beyoncé's film will begin Nov. 30. AMC is also selling tickets for "Renaissance: A Film by Beyoncé," with shows starting Nov. 30.
-James Rogers
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
10-06-23 1324ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Berkshire Hathaway Earnings: Strong Insurance Results Continue to Lift Revenue and Profitability
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom